Researchers Characterize Natural Compounds Revealed by FUSION Mapping

November 29, 2013

CTD2 researchers at University of Texas Southwestern Medical Center determined the structure and biosynthetic pathways of a family of natural compounds that inhibit the discoidin domain receptor 2 (DDR2) receptor pathway, which may contribute to growth and proliferation of some cancers. These results are published in the Journal of American Chemical Society.

Program:
CTD²
Last updated: October 30, 2018